HALEY LEWIS: Open Payments
NPI 1942746391 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,045 in 106 payments from 21 companies in 2025. Trend: 2023 $2,429 · 2024 $2,121 · 2025 $2,045
Food & beverage: $2,045
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $473 |
| AstraZeneca Pharmaceuticals LP | 16 | $270 |
| GlaxoSmithKline, LLC. | 10 | $200 |
| ABBVIE INC. | 12 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $153 |
| PFIZER INC. | 7 | $137 |
| Lilly USA, LLC | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| IDORSIA PHARMACEUTICALS US INC | 3 | $70 |
| Amgen Inc. | 4 | $66 |
Products named: Wegovy, TRELEGY ELLIPTA, Kerendia, FARXIGA, Ozempic, AIRSUPRA, MOUNJARO, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
